Cisapride
Specifications
81098-60-4CAS Number
279-689-7EC Number
4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamideIUPAC Name
C23H29ClFN3O4Chemical Formula
465.9 g/molMolecular Weight
cisapride; 81098-60-4; Cisaprida; Cisapridum; Enteropride; Kinestase; Pridesia; Prepulsid; R 51619; CHEBI:3720; UVL329170W; cis-4-Amino-5-chloro-N-(1-(3-(p-fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-o-anisamide; 4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide; R-51,619; R-51619; Benzamide, 4-amino-5-chloro-N-(1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-2-methoxy-, cis-; DTXSID3022825; 4-amino-5-chloro-N-((3S,4R)-1-(3-(4-fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide; Prepulsid quicklet; cis-4-amino-5-chloro-N-(1-(3-(p-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-o-anisamide; cis-4-amino-5-chloro-N-{1-[3-(p-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-o-anisamide; Propulsid Quicksolv; 4-Amino-5-chloro-N-(1-(3-(4-fluoro-phenoxy)-propyl)-3-methoxy-piperidin-4-yl)-2-methoxy-benzamide; 4-Amino-5-chloro-N-{(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl}-2-methoxybenzamide; 4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide; cis-4-amino-5-chloro-N-(1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-2-methoxybenzamide; cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide; RefChem:54832; R51619; A03FA02; DTXCID501508501; 279-689-7; 623-862-5; 4-amino-5-chloro-N-(1-(3-(4-fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide; (+-)-Cisapride; Acenalin; Risamol; 86718-70-9; Propulsid; CHEMBL560739; C23H29ClFN3O4; Propulsin; Acpulsif; Alipride; Cipride; Cisapron; Cisawal; Colinorm; Kaudalit; Rapulid; Syspride; Unipride; Vomiprid; Vomipride; Dispep; Esorid; Guptro; Presid; Pulsid; Unamol; Alimix Forte; 4-Amino-5-chloro-N-{(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide; Cisapridum [Latin]; Cisaprida [Spanish]; T 1341; SR-01000597514; 104860-66-4; Cisapridum [INN-Latin]; Cisaprida [INN-Spanish]; CISAPRIDE [JAN]; UNII-UVL329170W; HSDB 3571; EINECS 279-689-7; Cisapride (Standard); Cisapride [USAN:USP:INN:BAN:JAN]; CISAPRIDE [INN]; CISAPRIDE [MI]; CISAPRIDE [HSDB]; CISAPRIDE [USAN]; CISAPRIDE [VANDF]; CISAPRIDE [USP-RS]; CISAPRIDE [WHO-DD]; SCHEMBL16132; BIDD:GT0774; orb1223954; orb1309100; SCHEMBL29389140; CISAPRIDE [USP MONOGRAPH]; DCSUBABJRXZOMT-IRLDBZIGSA-N; HMS3268O13; HMS3412B22; HMS3676B22; GDA09860; MSK10215; BDBM50462032; EBC-09116; HY-14149R; NSC785572; AKOS024456750; DB00604; NSC-785572; AS-56067; Q425295; R 51619;( inverted exclamation markA)-Cisaprid; SR-01000597514-1; SR-01000597514-3; BRD-K06895174-001-01-0; BRD-K06895174-001-02-8; 4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidyl]-2-methoxy-benzamide; 4-amino-5-chloro-N-{cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl}-2-methoxybenzamide; BENZAMIDE, 4-AMINO-5-CHLORO-N-(1-(3-(4-FLUOROPHENOXY)PROPYL)-3-METHOXY-4-PIPERIDINYL)-2-METHOXY-, CISSynonyms
